BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 28, 2015
View Archived Issues
Studies examine pain relief, abuse potential with kappa opioid receptor agonist CR-845
Read More
Redx Pharma unveils BTK inhibitor for leukemia and autoimmune disease
Read More
Complete responses seen with AU-011 in rabbit model of uveal melanoma
Read More
Astellas Pharma reports phase I results for ASKP-1240
Read More
Novel TTSP inhibitors shows promise for the treatment of influenza
Read More
Fluconazole capsules approved for vulvovaginal candidasis in Japan
Read More
Researchers use miRNA to improve toxicity of oncolytic Mengovirus
Read More
BMS and uniQure close gene therapy collaboration transaction
Read More
Cellceutix initiates phase II trial of brilacidin-OM to prevent oral mucositis
Read More
Bluebird bio to develop CAR T-cell therapies for cancer using Five Prime technology
Read More
ADC Therapeutics and LivTech sign antibody license agreement
Read More
Inovio and GeneOne partner to advance DNA vaccine for MERS into clinic
Read More
World MS Day: New target for MS yields impressive results in vivo; compound ready for trials
Read More
Eisai seeks Japanese approval of mecobalamin for ALS
Read More
Jinarc approved in Europe for autosomal dominant polycystic kidney disease
Read More
Theravance grants SciClone development and commercial rights to Vibativ in China
Read More
FDA grants orphan drug designation to CRLX-101 for ovarian cancer
Read More
FDA accepts amended BLA for Coagadex
Read More
Proteostasis Therapeutics discloses USP14 inhibitors
Read More
Research at Bristol-Myers Squibb leads to development of new CKI inhibitors
Read More
IRAK-4 and TNF-alpha production inhibitors in early development at Takeda
Read More
Topline results from phase II study of GS-4774 in virally suppressed patients with chronic HBV
Read More
Neurogenesis stimulators described in recent Roche patent
Read More
Scynexis patent discloses antiparasitic compounds
Read More
FDA approves Viberzi and Xifaxan for IBS-D
Read More
Trelagliptin launched in Japan for type 2 diabetes
Read More